Insider trade

Officer received an award of 2,057 TMO shares

Traded Feb 25, 2026 · Filed Feb 27, 2026

Thermo Fisher ScientificTMO

2,057
Shares

Why it stands out

Compensation award — excluded from discretionary-purchase analysis.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Dates, kept separate

Transaction date: Feb 25, 2026
Reporting period: Not applicable
Filed with the SEC: Feb 27, 2026

OfficerGrant / award

Context

Classification

grant award

Code A — grant or award

Planned / mechanical clue

Footnote references vesting of compensation awards

Only flagged when a footnote says so; never inferred

Source receipt

Record ID: 0000097745-26-000030
Filed / recorded

Feb 27, 2026, 9:53 PM UTC

Added to OQRO

Oct 2, 2026, 12:28 PM UTC

Parser

form4-xml-v1

Data quality

Verified: identifiers matched exactly

Issuer

THERMO FISHER SCIENTIFIC INC.

Issuer CIK

97745

Ticker

TMO

Reporting person

Gianluca Pettiti

Relationship

Officer

Officer title

Executive Vice President

Security

Common Stock

Table

Non-derivative (Table I)

Transaction date

Feb 25, 2026

Transaction code

A

Shares / units

2,057

Price per share

$0.00

Acquired / disposed

Acquired (A)

Shares owned after

22,809.223

Ownership form

Direct

Amendment

No

Footnotes from the filing

Shares represent a performance-based restricted stock unit award granted on February 19, 2025. The Company's Compensation Committee determined on February 25, 2026, that the performance criteria related to this award were satisfied. One-third of the shares vest on February 28, 2026 and 2027. The remaining one-third will vest on February 28, 2028, and is subject to adjustment (positive or negative) for long-term performance which is based on the comparison of the Company's total shareholder return compound annual growth rate ("CAGR") to the total shareholder return CAGR of each of the companies in the peer group, as specified within the award agreement, over the measurement period starting on January 1, 2025, through to December 31, 2027.

Around the same time

Officer sold ~$803K of Thermo Fisher Scientific

Scheduled in advance7mo ago

7mo ago

4,000Shares · @ $309.63

Derivative exercise or conversion — not an open-market buy.

Why it stands out Official record

CEO sold ~$10K of Thermo Fisher Scientific

Scheduled in advance7mo ago